Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Baxter
Dow
McKesson
AstraZeneca

Last Updated: September 28, 2022

Litigation Details for Gilead Sciences Inc. v. Abbvie Inc. (D. Del. 2013)


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Gilead Sciences Inc. v. Abbvie Inc. (D. Del. 2013)

Docket See Plans and Pricing Date Filed 2013-12-17
Court District Court, D. Delaware Date Terminated 2016-08-24
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand Plaintiff Referred To
Parties ABBVIE IRELAND UNLIMITED COMPANY
Patents 7,964,580; 8,088,368; 8,273,341; 8,334,270; 8,466,159; 8,492,386; 8,580,765; 8,680,106; 8,685,984
Attorneys Douglas Edward McCann
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Gilead Sciences Inc. v. Abbvie Inc.
The small molecule drugs covered by the patents cited in this case are See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , and See Plans and Pricing .

Details for Gilead Sciences Inc. v. Abbvie Inc. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2015-11-02 236 asserted claims of U.S. Patent Nos. 8,466,159 (the'" 159 Patent") and 8,492,386 (the … ORDER CONSTRUING THE TERMS OF U.S. PATENT NOs. 8,466,159 & 8,492,386. Signed by Judge Gregory M. … ORDER CONSTRUING THE TERMS OF U.S. PATENT NOs. 8,466,159 & 8,492,386 After having considered…the '"386 Patent"): The term "treatment for HCV" is construed to have its…language of the claim in construing the terms of a patent. Vitronics Corp. v. Conceptronic, Inc., 90 F.3d External link to document
2014-04-10 32 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,466,159 B2; US 8,492,386 …2013 24 August 2016 1:13-cv-02034 830 Patent Plaintiff District Court, D. Delaware External link to document
2014-04-10 33 States patent laws. Both PSI-7977 and GS-5885 are protected by United States Patents Nos.7,964,580, 8,334,270…protected by several United States patents, including U.S. Patent Nos. 7,964,580, 8,334,270, and 8,580,765. …violating the U.S. Patent Law. Gilead Pharmasset LLC owns U.S. Patent No. 7,964,580, which covers PSI…including, among others U.S. Patent No. 7,964,580 B2 (“the Gilead ’580 patent”) and U.S. …2690 limited to the following issued U.S. Patents: 7,964,580, 8,334,270, and 8,580,765 (PSI/GS-7977 - External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Baxter
Express Scripts
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.